📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial. (2016)

First Author: BREATHER (PENTA 16) Trial Group

Attributed to: Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(16)30054-6

PubMed Identifier: 27562743

Publication URI: http://europepmc.org/abstract/MED/27562743

Type: Journal Article/Review

Volume: 3

Parent Publication: The lancet. HIV

Issue: 9

ISSN: 2352-3018